Roivant Sciences Ltd. (ROIV)

35.72 +0.22 (+0.62%) USD  |  NASDAQ  |  Oct 02, 16:00
35.68 -0.04 (-0.11%) After-Hours: 20:00
More

Roivant Sciences EPS Diluted (Quarterly) : -0.2634 for June 30, 2026

EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 -0.2634
March 31, 2026 0.373
December 31, 2025 -0.3816
September 30, 2025 -0.1667
June 30, 2025 -0.3283
March 31, 2025 -0.2919
December 31, 2024 0.2344
September 30, 2024 -0.313
June 30, 2024 0.1219
March 31, 2024 -0.1882
December 31, 2023 6.035
September 30, 2023 -0.3951
Date Value
June 30, 2023 -0.3843
March 31, 2023 -0.0453
December 31, 2022 -0.4935
September 30, 2022 -0.4166
June 30, 2022 -0.4768
March 31, 2022 -0.3899
December 31, 2021 -0.4144
September 30, 2021 -0.3206
June 30, 2021 -0.3701
March 31, 2021 -2.288
March 31, 2020 -0.2771

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Oxford Biomedica Plc --
Bicycle Therapeutics Plc -0.7224
Arbutus Biopharma Corp. -0.026
Adaptimmune Therapeutics Plc -0.1163
Kiniksa Pharmaceuticals International Plc 0.305

EPS Diluted (Quarterly) Related Metrics

Net Income (Quarterly) -290.61M
Revenue (Quarterly) 1.442M
Total Expenses (Quarterly) 191.28M
Enterprise Value 22.77B
Gross Profit Margin (Quarterly) 38.70%
Profit Margin (Quarterly) -20.15K%
Earnings Yield -1.23%
Normalized Earnings Yield -3.426